Floatz logo

Cytosin-Arabinosid

Hematopoietic Stem Cell Mobilization

The Affiliated People's Hospital of Ningbo UniversityPhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

16 Active assets in the Hematopoietic Stem Cell Mobilization cohort.

Asset / SponsorPhaseRating
Ifosfamide
The Affiliated People's Hospital of Ningbo University
Phase 3B
PEGFILGRASTIM
The Affiliated People's Hospital of Ningbo University
Phase 3B
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
The Affiliated People's Hospital of Ningbo University
Phase 3B
Cyclophosphamide
The Affiliated People's Hospital of Ningbo University
Phase 3B
Mesna
The Affiliated People's Hospital of Ningbo University
Phase 3B

View all 16 →

Same molecule, other indications

Cytosin-Arabinosid is also rated in:

acute promyelocytic leukemiaDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →